Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check60 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study methodology and inclusion criteria for a clinical trial on recurrent and metastatic salivary gland carcinoma, while a new revision number has been added.SummaryDifference37%
- Check67 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.